Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism Methyltransferase inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC15H21F3N6 |
InChIKeyZLMRFHOUTWHVBE-UHFFFAOYSA-N |
CAS Registry1061348-41-1 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Leishmaniasis | Preclinical | Ghana | 21 Feb 2023 | |
| Leishmaniasis | Preclinical | Ghana | 21 Feb 2023 |





